Molecular docking study on quercetin derivatives as inhibitors of pantothenatesynthetase (Panc) of mycobacterium tuberculosis

4Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The anti-TB drugs currently in the use are insufficient to address these major health challenges. Hence, it is imperative to discover and develop new and efficient drugs against TB. The enzyme pantothenate synthetase (PS or PanC), necessary for the production of pantothenate (vitamin B5), critical components of fatty acid synthesis, when inhibited will in turn affect the cell wall synthesis of bacilli. In the present study, an attempt will be made to find the drug like molecules from quercetin derivatives prepared in silico to find out possible inhibitors of PanCof M. tuberculosis. The 3D structure of PanC was obtained from RCSB database and quercetin from ZINC database. The derivatives of quercetin were prepared and were docked initially with iGEMDOCK docking tool. The final docking was done in AutoDock vina software. The ADMET properties of the selected ligands were done in admetSAR online server tool. The present study revealed that four derivatives of quercetin has excellent binding with Pantothenate Synthetase (PanC) of M. tuberculosis. These derivatives can be taken for in vitro enzymatic assays for its inhibitory property in the search for new anti-TB drugs.

Cite

CITATION STYLE

APA

Premalatha, E., Dineshraj, R., Kannan, I., Bhaarath, K. S., & Sharavanan, T. K. V. (2020). Molecular docking study on quercetin derivatives as inhibitors of pantothenatesynthetase (Panc) of mycobacterium tuberculosis. International Journal of Research in Pharmaceutical Sciences, 11(3), 3684–3690. https://doi.org/10.26452/ijrps.v11i3.2529

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free